PDSB
PDS Biotechnology (PDSB)
$25
About PDS Biotechnology (PDSB)
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products include PDS0101 and PDS01ADC. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Details
Daily high
$1.29
Daily low
$1.14
Price at open
$1.16
52 Week High
$1.92
52 Week Low
$0.51
Market cap
63.6M
Dividend yield
0.00%
Volume
24,363
Avg. volume
987,673
P/E ratio
-1.52
PDS Biotechnology News
Details
Daily high
$1.29
Daily low
$1.14
Price at open
$1.16
52 Week High
$1.92
52 Week Low
$0.51
Market cap
63.6M
Dividend yield
0.00%
Volume
24,363
Avg. volume
987,673
P/E ratio
-1.52